Differential kinetics of intracellular caspase-1-like and caspase-3-like enzyme activity in human alloreactive CD4+ and CD8+ T cells undergoing apoptosis

Phillip Ruiz, Larry Coleman, Fang Wang, Jay Enten

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The ICE-like families of serine proteases (caspases) have integral roles in apoptosis. These studies were performed to further understand the role of two critical caspases in relation to apoptotic regulation of the alloimmune response. A novel three-color cytofluorographic technique was utilized for measuring intracellular (in situ) caspase-1-like and caspase-3-like enzyme activity in responding CD4+ and CD8+ T cells over several time points of human mixed lymphocyte reactions (MLR). We found that activity levels of caspase 3 in both CD4+ and CD8+ responder cells began rising at day 10 of the MLR and peaked at day 14. By comparison, caspase 1 demonstrated the highest activity at day 7 in both cell subpopulations. These results coincided with the appearance of apoptotic cells among the alloreactive cells in the MLR. These findings demonstrate that intracellular caspase-1- and -3-like enzyme activity increases in both CD4+ and CD8+ alloreactive T cells as the primary response to allostimulatory cells progresses. While the kinetic profiles for these enzymes differed, both had a temporal association with the appearance of apoptosis in the MLR-generated cells. In all cases, the highest enzyme activity and presence of apoptosis was seen subsequent to the peak proliferative period. These results support the concept that changes in the rate and amount of apoptosis in alloreactive T cells is one mechanism by which the response to alloantigens is attenuated (i.e., tolerance) or sustained.

Original languageEnglish
Pages (from-to)308-312
Number of pages5
JournalClinical Immunology
Volume98
Issue number3
DOIs
StatePublished - Mar 21 2001

Fingerprint

Caspase 1
Human Activities
Caspase 3
Mixed Lymphocyte Culture Test
Apoptosis
T-Lymphocytes
Enzymes
Caspases
Isoantigens
Serine Proteases
Color

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pathology and Forensic Medicine

Cite this

Differential kinetics of intracellular caspase-1-like and caspase-3-like enzyme activity in human alloreactive CD4+ and CD8+ T cells undergoing apoptosis. / Ruiz, Phillip; Coleman, Larry; Wang, Fang; Enten, Jay.

In: Clinical Immunology, Vol. 98, No. 3, 21.03.2001, p. 308-312.

Research output: Contribution to journalArticle

@article{7f17fb24cc3a4aeb8da836640b02a9cb,
title = "Differential kinetics of intracellular caspase-1-like and caspase-3-like enzyme activity in human alloreactive CD4+ and CD8+ T cells undergoing apoptosis",
abstract = "The ICE-like families of serine proteases (caspases) have integral roles in apoptosis. These studies were performed to further understand the role of two critical caspases in relation to apoptotic regulation of the alloimmune response. A novel three-color cytofluorographic technique was utilized for measuring intracellular (in situ) caspase-1-like and caspase-3-like enzyme activity in responding CD4+ and CD8+ T cells over several time points of human mixed lymphocyte reactions (MLR). We found that activity levels of caspase 3 in both CD4+ and CD8+ responder cells began rising at day 10 of the MLR and peaked at day 14. By comparison, caspase 1 demonstrated the highest activity at day 7 in both cell subpopulations. These results coincided with the appearance of apoptotic cells among the alloreactive cells in the MLR. These findings demonstrate that intracellular caspase-1- and -3-like enzyme activity increases in both CD4+ and CD8+ alloreactive T cells as the primary response to allostimulatory cells progresses. While the kinetic profiles for these enzymes differed, both had a temporal association with the appearance of apoptosis in the MLR-generated cells. In all cases, the highest enzyme activity and presence of apoptosis was seen subsequent to the peak proliferative period. These results support the concept that changes in the rate and amount of apoptosis in alloreactive T cells is one mechanism by which the response to alloantigens is attenuated (i.e., tolerance) or sustained.",
author = "Phillip Ruiz and Larry Coleman and Fang Wang and Jay Enten",
year = "2001",
month = "3",
day = "21",
doi = "10.1006/clim.2001.4981",
language = "English",
volume = "98",
pages = "308--312",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Differential kinetics of intracellular caspase-1-like and caspase-3-like enzyme activity in human alloreactive CD4+ and CD8+ T cells undergoing apoptosis

AU - Ruiz, Phillip

AU - Coleman, Larry

AU - Wang, Fang

AU - Enten, Jay

PY - 2001/3/21

Y1 - 2001/3/21

N2 - The ICE-like families of serine proteases (caspases) have integral roles in apoptosis. These studies were performed to further understand the role of two critical caspases in relation to apoptotic regulation of the alloimmune response. A novel three-color cytofluorographic technique was utilized for measuring intracellular (in situ) caspase-1-like and caspase-3-like enzyme activity in responding CD4+ and CD8+ T cells over several time points of human mixed lymphocyte reactions (MLR). We found that activity levels of caspase 3 in both CD4+ and CD8+ responder cells began rising at day 10 of the MLR and peaked at day 14. By comparison, caspase 1 demonstrated the highest activity at day 7 in both cell subpopulations. These results coincided with the appearance of apoptotic cells among the alloreactive cells in the MLR. These findings demonstrate that intracellular caspase-1- and -3-like enzyme activity increases in both CD4+ and CD8+ alloreactive T cells as the primary response to allostimulatory cells progresses. While the kinetic profiles for these enzymes differed, both had a temporal association with the appearance of apoptosis in the MLR-generated cells. In all cases, the highest enzyme activity and presence of apoptosis was seen subsequent to the peak proliferative period. These results support the concept that changes in the rate and amount of apoptosis in alloreactive T cells is one mechanism by which the response to alloantigens is attenuated (i.e., tolerance) or sustained.

AB - The ICE-like families of serine proteases (caspases) have integral roles in apoptosis. These studies were performed to further understand the role of two critical caspases in relation to apoptotic regulation of the alloimmune response. A novel three-color cytofluorographic technique was utilized for measuring intracellular (in situ) caspase-1-like and caspase-3-like enzyme activity in responding CD4+ and CD8+ T cells over several time points of human mixed lymphocyte reactions (MLR). We found that activity levels of caspase 3 in both CD4+ and CD8+ responder cells began rising at day 10 of the MLR and peaked at day 14. By comparison, caspase 1 demonstrated the highest activity at day 7 in both cell subpopulations. These results coincided with the appearance of apoptotic cells among the alloreactive cells in the MLR. These findings demonstrate that intracellular caspase-1- and -3-like enzyme activity increases in both CD4+ and CD8+ alloreactive T cells as the primary response to allostimulatory cells progresses. While the kinetic profiles for these enzymes differed, both had a temporal association with the appearance of apoptosis in the MLR-generated cells. In all cases, the highest enzyme activity and presence of apoptosis was seen subsequent to the peak proliferative period. These results support the concept that changes in the rate and amount of apoptosis in alloreactive T cells is one mechanism by which the response to alloantigens is attenuated (i.e., tolerance) or sustained.

UR - http://www.scopus.com/inward/record.url?scp=0035090059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035090059&partnerID=8YFLogxK

U2 - 10.1006/clim.2001.4981

DO - 10.1006/clim.2001.4981

M3 - Article

C2 - 11237553

AN - SCOPUS:0035090059

VL - 98

SP - 308

EP - 312

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 3

ER -